Psychopathological symptoms during interferon-α and ribavirin treatment: effects on virologic response
- 18 January 2005
- journal article
- Published by Springer Nature in Molecular Psychiatry
- Vol. 10 (4), 332-333
- https://doi.org/10.1038/sj.mp.4001634
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Depressive symptoms and viral clearance in patients receiving interferon-α and ribavirin for hepatitis CBrain, Behavior, and Immunity, 2005
- Association of interferon-α-induced depression and improved treatment response in patients with hepatitis CNeuroscience Letters, 2004
- Psychopharmacological Treatment of Depression, Anxiety, Irritability and Insomnia in Patients Receiving Interferon-α: a Prospective Case Series and a Discussion of Biological MechanismsJournal of Psychopharmacology, 2004
- Interferon Alfa–Induced Adverse Effects in Patients with a Psychiatric DiagnosisNew England Journal of Medicine, 2002
- Neurobehavioral Effects of Interferon-α in Cancer Patients Phenomenology and Paroxetine Responsiveness of Symptom DimensionsNeuropsychopharmacology, 2002
- Treatment with interferon-α in patients with chronic hepatitis and mood or anxiety disordersThe Lancet, 1999
- Development of a fatigue scaleJournal of Psychosomatic Research, 1993
- Measuring Functioning and Well-Being: The Medical Outcomes Study ApproachPublished by Rand Corporation ,1992
- An Inventory for Measuring DepressionArchives of General Psychiatry, 1961